Established in 2013, Maxpro Ventures is a biomedical technology investment firm identifying companies developing innovative drugs, devices, diagnostics, and services to fulfill people’s unmet medical needs and change their lives. We primarily focus on companies developing next-generation cell/gene therapies, biolo1gic drugs, medical devices, diagnostics, and healthcare services.
​
At Maxpro Ventures, we create and discover value in the biomedical technology industry. We have been investing globally across the healthcare industry, from early-stage small companies to late-stage multinational corporations. We are committed investors and work closely with our portfolio companies to maximize their profits and success.
​
Maxpro Ventures’ team includes experienced professionals with in-depth knowledge of biotechnology, pharmaceuticals, business development, and finance. We provide our portfolio companies with operational expertise, management support, and a global network. We leverage our extensive relationships, industry operating experience, and a disciplined investment approach to add considerable value to our portfolio companies and to generate substantial investment returns for our investors.